168 related articles for article (PubMed ID: 37382903)
1. Dolutegravir-induced neural tube defects in mice are folate responsive.
Tukeman GL; Wei H; Lin YL; Wlodarczyk BJ; Finnell RH; Cabrera RM
AIDS; 2024 Mar; 38(4):439-446. PubMed ID: 37382903
[TBL] [Abstract][Full Text] [Related]
2. Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels.
Mohan H; Lenis MG; Laurette EY; Tejada O; Sanghvi T; Leung KY; Cahill LS; Sled JG; Delgado-Olguín P; Greene NDE; Copp AJ; Serghides L
EBioMedicine; 2021 Jan; 63():103167. PubMed ID: 33341441
[TBL] [Abstract][Full Text] [Related]
3. The antagonism of folate receptor by dolutegravir: developmental toxicity reduction by supplemental folic acid.
Cabrera RM; Souder JP; Steele JW; Yeo L; Tukeman G; Gorelick DA; Finnell RH
AIDS; 2019 Nov; 33(13):1967-1976. PubMed ID: 31259764
[TBL] [Abstract][Full Text] [Related]
4. Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.
Mofenson LM; Pozniak AL; Wambui J; Raizes E; Ciaranello A; Clayden P; Ehrenkranz P; Fakoya A; Hill A; Khoo S; Mahaka I; Modi S; Moore C; Phillips A; Siberry G; Sikwese K; Thorne C; Watts HD; Doherty M; Ford NP
J Int AIDS Soc; 2019 Jul; 22(7):e25352. PubMed ID: 31298496
[TBL] [Abstract][Full Text] [Related]
5. Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study.
Pereira GFM; Kim A; Jalil EM; Fernandes Fonseca F; Shepherd BE; Veloso VG; Rick F; Ribeiro R; Pimenta MC; Beber A; Corrêa RG; Lima R; Maruri F; McGowan CC; Schwartz Benzaken A; Grinsztejn B; Castilho JL;
Lancet HIV; 2021 Jan; 8(1):e33-e41. PubMed ID: 33387477
[TBL] [Abstract][Full Text] [Related]
6. Folate deficiency increases the incidence of dolutegravir-associated foetal defects in a mouse pregnancy model.
Mohan H; Nguyen J; MacKenzie B; Yee A; Laurette EY; Sanghvi T; Tejada O; Dontsova V; Leung KY; Goddard C; De Young T; Sled JG; Greene NDE; Copp AJ; Serghides L
EBioMedicine; 2023 Sep; 95():104762. PubMed ID: 37586112
[TBL] [Abstract][Full Text] [Related]
7. Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa.
Chandiwana NC; Chersich M; Venter WDF; Akpomiemie G; Hill A; Simmons B; Lockman S; Serenata CM; Fairlie L; Moorhouse MA
AIDS; 2021 Feb; 35(2):205-211. PubMed ID: 33086234
[TBL] [Abstract][Full Text] [Related]
8. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.
Zash R; Holmes L; Diseko M; Jacobson DL; Brummel S; Mayondi G; Isaacson A; Davey S; Mabuta J; Mmalane M; Gaolathe T; Essex M; Lockman S; Makhema J; Shapiro RL
N Engl J Med; 2019 Aug; 381(9):827-840. PubMed ID: 31329379
[TBL] [Abstract][Full Text] [Related]
9. Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Kreitchmann R; Oliveira FR; Sprinz E
Braz J Infect Dis; 2021; 25(2):101572. PubMed ID: 33852885
[TBL] [Abstract][Full Text] [Related]
10. Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects.
Martiniova L; Field MS; Finkelstein JL; Perry CA; Stover PJ
Am J Clin Nutr; 2015 Apr; 101(4):860-9. PubMed ID: 25833982
[TBL] [Abstract][Full Text] [Related]
11. Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.
Dugdale CM; Ciaranello AL; Bekker LG; Stern ME; Myer L; Wood R; Sax PE; Abrams EJ; Freedberg KA; Walensky RP
Ann Intern Med; 2019 May; 170(9):614-625. PubMed ID: 30934067
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Dolutegravir and Folic Acid Interaction during Neural System Development in Zebrafish Embryos.
Zizioli D; Quiros-Roldan E; Ferretti S; Mignani L; Tiecco G; Monti E; Castelli F; Zanella I
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731859
[TBL] [Abstract][Full Text] [Related]
14. Interaction between dolutegravir and folate transporters and receptor in human and rodent placenta.
Gilmore JC; Hoque MT; Dai W; Mohan H; Dunk C; Serghides L; Bendayan R
EBioMedicine; 2022 Jan; 75():103771. PubMed ID: 34954655
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy.
van De Ven NS; Pozniak AL; Levi JA; Clayden P; Garratt A; Redd C; Mofenson LM; Hill A
Clin Infect Dis; 2020 Jun; 70(12):2599-2606. PubMed ID: 31595301
[TBL] [Abstract][Full Text] [Related]
16. Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.
Zash R; Makhema J; Shapiro RL
N Engl J Med; 2018 Sep; 379(10):979-981. PubMed ID: 30037297
[No Abstract] [Full Text] [Related]
17. Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.
Zamek-Gliszczynski MJ; Zhang X; Mudunuru J; Du Y; Chen JL; Taskar KS; Huang J; Huang Y; Romach EH
Drug Metab Dispos; 2019 Aug; 47(8):890-898. PubMed ID: 31167838
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
Padmanabhan R; Shafiullah MM
Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
[TBL] [Abstract][Full Text] [Related]
19. No developmental toxicity observed with dolutegravir in rat whole embryo culture.
Posobiec LM; Chapman SP; Murzyn SF; Rendemonti JE; Stanislaus DJ; Romach EH
Birth Defects Res; 2021 Oct; 113(16):1190-1197. PubMed ID: 34453500
[TBL] [Abstract][Full Text] [Related]
20. Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana.
Davey S; Ajibola G; Maswabi K; Sakoi M; Bennett K; Hughes MD; Isaacson A; Diseko M; Zash R; Batlang O; Moyo S; Lockman S; Lichterfeld M; Kuritzkes DR; Makhema J; Shapiro R
J Acquir Immune Defic Syndr; 2020 Jul; 84(3):235-241. PubMed ID: 32195745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
